Patent intelligence · US
US 12121828
Systems and methods of isolation of gallium-68
Systems and methods of isolation of gallium-68
Patent details — US 12121828
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 22, 2024
- Expiration
- Oct 17, 2044
- Applicant
- Telix ARTMS Inc.
- Claims
- 21
- CPC classes
- A61K, A61K51/0402, A61K51/0497, A61K51/083
Quick answer
US 12121828 (Systems and methods of isolation of gallium-68) is held by Telix ARTMS Inc.. Status: granted. Granted Oct 22, 2024. Expires Oct 17, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Telix ARTMS Inc.
- Grant date
- Expiration
- Claims
- 21
- CPC classes
- A61K, A61K51/0402, A61K51/0497, A61K51/083, A61K51/088
More from Telix ARTMS Inc.
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 12121828?
US 12121828 (Systems and methods of isolation of gallium-68) is held by Telix ARTMS Inc.. Status: granted. Granted Oct 22, 2024. Expires Oct 17, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12121828?
Telix ARTMS Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 3 pharmaceutical patents for this assignee.
When does US 12121828 expire?
Our index shows an expiration date of Oct 17, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.